Redhill Biopharma Ltd Ord

(REDIF)

By |

Profile

Redhill Biopharma Ltd is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. RedHill's pipeline includes several drug candidates in advanced clinical development stages, including three Phase III-stage programs. Its late clinical-stage pipeline includes TALICIA(r) (RHB-105), RHB-104, RHB-204, BEKINDA(r) (RHB-102), YELIVA(r) (ABC294640), RHB-106 and RHB-107. The company also commercializes and promotes gastrointestinal products in the United States.

Contact Information

Website: www.redhillbio.com
Email: info@redhillbio.com
Main Phone: +972 35413131
Address: 21 Ha'arba'a Street
City / Town: Tel Aviv
Country: ISR
Postal Code: 64739

Issuer Information

Exchange: GREY
CEO: Dror Ben-Asher
Employees: 74
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.75 $ 0. (0.00%)
Last Price 0.75 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.75
Last Trade Volume 0 52 Wk Hi 0.97 52 Wk Low 0.75
Market Cap 160.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 213,439,434.00 EPS (TTM) -0.25 PE Ratio N/A Exchange Greys